Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

TELESTA THERAPEUTICS INC T.TST

"Telesta Therapeutics Inc is a biopharmaceutical company. The Company is engaged in the research, development, manufacturing and commercialization of human health products and technologies."


TSX:TST - Post by User

Post by high2on Feb 03, 2016 10:28am
204 Views
Post# 24519718

New project for TST

New project for TSTI hear rumours that TST i slooking fo rnew proejcts in the bladder cancer field.

this might be an ideal fit given TST has teh cash to see this thru.

Executive Summary

I
 
n the 50’s, we watched black and white TV’s. Now in 2016, we watch HD, color television with picture clarity and depth. It is simply a different experience. By way of analogy, we are bringing this same technological advancement to the urologist looking for bladder cancer.
 
 https://imaginmedical.com


Company Overview
Imagin Medical is a medical imaging company that believes it will radically improve the way physicians detect cancer through the use of endoscopes to image and visualize cancer and/or cancer markers. Dr. Stavros Demos from the renowned Lawrence Livermore National Laboratory (LLNL) is the inventor of a combination optical/laser technology that uses white light and near-infrared fluorescence for the accurate visual detection of cancer. Dr. Demos worked in collaboration with the UC Davis Comprehensive Cancer Center and Dr. Ralph deVere White, one of the world’s leading authorities on bladder cancer, for more than five years to validate this technology. The Company has entered into a partnership with the LLNL and UC Davis to complete the clinical evaluations that will support the Company’s FDA submission. Imagin holds the exclusive license to this intellectual property.
<< Previous
Bullboard Posts
Next >>